Cargando…

Immune Checkpoint B7x (B7-H4/B7S1/VTCN1) is Over Expressed in Spontaneous Canine Bladder Cancer: The First Report and its Implications in a Preclinical Model

BACKGROUND: B7x (B7-H4/B7S1/VTCN1), an inhibitory immune checkpoint molecule is a potential therapeutic target owing to its immunosuppressive effect and well-known expression in cancers. Immune checkpoints in canine bladder cancer are largely undefined. Here, we report the first evaluation on expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chand, Damini, Dhawan, Deepika, Sankin, Alexander, Ren, Xiaoxin, Lin, Juan, Schoenberg, Mark, Knapp, Deborah W., Zang, Xingxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2019
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401562/ https://www.ncbi.nlm.nih.gov/pubmed/30854414 http://dx.doi.org/10.3233/BLC-180204

Ejemplares similares

Nardilysin-Dependent Proteolysis of Cell-Associated VTCN1 (B7-H4) Marks Type 1 Diabetes Development
por: Radichev, Ilian A., et al.
Publicado: (2014)

The immune checkpoint molecule, VTCN1/B7-H4, guides differentiation and suppresses proinflammatory responses and MHC class I expression in an embryonic stem cell-derived model of human trophoblast
por: Zhou, Jie, et al.
Publicado: (2023)

MEDB-76. Evaluating the B7-H3 checkpoint in Medulloblastoma
por: Moziak, Kirsten, et al.
Publicado: (2022)

Crosstalk between the B7/CD28 and EGFR pathways: Mechanisms and therapeutic opportunities
por: Ren, Xiaoxin, et al.
Publicado: (2021)

The PD-1/PD-L1 (B7-H1) Pathway in Chronic Infection-Induced Cytotoxic T Lymphocyte Exhaustion
por: Hofmeyer, Kimberly A., et al.
Publicado: (2011)

SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models
por: Gray, Elizabeth, et al.
Publicado: (2023)

The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy
por: John, Peter, et al.
Publicado: (2022)

The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development
por: Picarda, Elodie, et al.
Publicado: (2022)

Expression of B7 Homolog 1 (B7H1) Is Associated with Clinicopathologic Features in Urothelial Bladder Cancer
por: Li, Qingyuan, et al.
Publicado: (2018)

Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways
por: Wang, Feng, et al.
Publicado: (2023)

Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function
Publicado: (1994)

Association of the canine ATP7A and ATP7B with hepatic copper accumulation in Dobermann dogs
por: Wu, Xiaoyan, et al.
Publicado: (2019)

The co-inhibitory immune checkpoint proteins B7-H1(PD-L1) and B7-H4 in high grade glioma: From bench to bedside
por: Qi, Ying, et al.
Publicado: (2023)

The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer
por: Chen, Yan, et al.
Publicado: (2014)

Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer
por: XU, MEI, et al.
Publicado: (2016)

7-Phenyl-7H-dinaphtho[2,1-b:1′,2′-d]phosphole 7-oxide
por: Yao, Lan, et al.
Publicado: (2011)

Tumor-expressed immune checkpoint B7x promotes cancer progression and antigen-specific CD8 T cell exhaustion and suppressive innate immune cells
por: Ohaegbulam, Kim C., et al.
Publicado: (2017)

Pediatric medulloblastoma express immune checkpoint B7-H3
por: Li, S., et al.
Publicado: (2022)

Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancer
por: Bazhin, Alexandr V., et al.
Publicado: (2022)

The Coexpression and Clinical Significance of Costimulatory Molecules B7-H1, B7-H3, and B7-H4 in Human Pancreatic Cancer [Retraction]
Publicado: (2022)

Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer
por: Li, Yuxin, et al.
Publicado: (2020)

Upregulation of the B7/CD28 family member B7-H3 in bladder cancer
por: WU, DEYAO, et al.
Publicado: (2015)

Transistor Properties of 2,7-Dialkyl-Substituted Phenanthro[2,1-b:7,8-b′]dithiophene
por: Kubozono, Yoshihiro, et al.
Publicado: (2016)

Synthesis and Physicochemical Properties of 2,7-Disubstituted Phenanthro[2,1-b:7,8-b’]dithiophenes
por: Ji, Zhenfei, et al.
Publicado: (2020)

Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
por: Wei, Joyce, et al.
Publicado: (2011)

B7x and myeloid-derived suppressor cells in the tumor microenvironment: A tale of two cities
por: Jeon, Hyungjun, et al.
Publicado: (2013)

Perinatal Blockade of B7-1 and B7-2 Inhibits Clonal Deletion of Highly Pathogenic Autoreactive T Cells
por: Gao, Jian-Xin, et al.
Publicado: (2002)

Radiomorphological signs and clinical severity of SARS-CoV-2 lineage B.1.1.7
por: Simon, Judit, et al.
Publicado: (2022)

The B7 family molecules in oral squamous cell carcinoma: a systematic review. Part I: B7-H1 (PD-L1) and B7-DC (PD-L2)
por: Starzyńska, Anna, et al.
Publicado: (2020)

Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene
por: Pyke, Alyssa T., et al.
Publicado: (2021)

Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
por: Qin, Xiaoyan, et al.
Publicado: (2021)

B7 score and T cell infiltration stratify immune status in prostate cancer
por: Zhou, Qianghua, et al.
Publicado: (2021)

7-Phenylsulfonyl-2,3-dihydro-7H-1,4-benzodioxino[6,7-b]carbazole
por: Kanchanadevi, J., et al.
Publicado: (2010)

Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10.
por: Dummer, R., et al.
Publicado: (1998)

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma
por: Wang, Yuelong, et al.
Publicado: (2020)

Molecular Modeling and Functional Mapping of B7-H1 and B7-DC Uncouple Costimulatory Function from PD-1 Interaction
por: Wang, Shengdian, et al.
Publicado: (2003)

Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
por: Qin, Xiaoyan, et al.
Publicado: (2023)

B7-H3, a checkpoint molecule, as a target for cancer immunotherapy
por: Yang, Shuo, et al.
Publicado: (2020)

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
por: Zhao, Binghao, et al.
Publicado: (2022)

$^{7}$B(p,$\gamma$)$^{8}$B revisited
por: Bertulani, C A
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_j6nabmde5s4133j52ih8mpl6tn